Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.

Autor: Stölzl, D., Sander, N., Siegels, D., Harder, I., Kind, B., Fonfara, M., Heinrich, L., Ott, Hagen, Abraham, S., Neustädter, I., Kleinheinz, A., Gerdes, S., Wollenberg, A., Lau, S., Nemat, K., Heratizadeh, A., Gellhaus, I., Werfel, T., Schmitt, J., Weidinger, S.

Publikováno v: Allergy; Oct2024, Vol. 79 Issue 10, p2849-2852, 4p

A new era of biological therapeutics in atopic dermatitis? Treatment of moderate-to-severe atopic dermatitis after the approval of the first biologic agent: results from the german national registry TREATgermany

Autor: Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., Wollenberg, A., Zink, A., Radtke, M. A., Gerlach, B., Hilgers, M., Worm, M., Kiedrowski, R., Wiemers, F., Staubach-Renz, P., Pawlak, M., Bell, M., Schäkel, K., Fell, I., Handrick, C., Asmussen, A., Bieber, T., Neubert, K., Homey, B., Schwarz, B., Isaak Effendy, Beissert, S., Werfel, T., Schmitt, J., Weidinger, S.

Publikováno v: PUB-Publications at Bielefeld University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eafcaeeee77ceb4449228c32910d8796
https://pub.uni-bielefeld.de/record/2968773

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany.

Autor: Heratizadeh, A., Haufe, E., Stölzl, D., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Augustin, M., Wiemers, F., Zink, A., Kiedrowski, R., Hilgers, M., Worm, M., Pawlak, M., Sticherling, M., Fell, I., Handrick, C., Schäkel, K., Staubach‐Renz, P.

Publikováno v: Journal of the European Academy of Dermatology & Venereology; Jun2020, Vol. 34 Issue 6, p1263-1272, 10p

092 Real-World data on efficacy, safety and persistence of dupilumab: An analysis from the TREATgermany registry

Autor: Sander, N., Stölzl, D., Heratizdaeh, A., Haufe, E., Harder, I., Schmitt, J., Werfel, T., Weidinger, S.

Publikováno v: Journal of Investigative Dermatology; December 2022, Vol. 142 Issue: 12, Number 12 Supplement 1 pS196-S196, 1p

Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients.

Autor: Dekkers C; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Smits H; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Stölzl D; Department of Dermatology and Allergology, Dermatology University Hospital, Kiel, Germany., Spekhorst L; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Knol E; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., van Wijk F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Harder I; Department of Dermatology and Allergology, Dermatology University Hospital, Kiel, Germany., Werfel T; Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany., Schmitt J; Center for Evidence-Based Healthcare, Medical Faculty and University Hospital Carl Gustav Carus, Dresden, Germany., Kleinheinz A; Clinics for Dermatology, Elbe Klinikum Buxtehude, Buxtehude, Germany., Abraham S; University Allergy Center, Medical Faculty, Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Thijs J; Department of Dermatology, Meander Medical Center Amersfoort, Amersfoort, The Netherlands., Weidinger S; Department of Dermatology and Allergology, Dermatology University Hospital, Kiel, Germany., de Bruin-Weller M; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Bakker D; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands., Drylewicz J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.